Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3269727 | HPB | 2011 | 6 Pages |
Abstract
Staging laparoscopy becomes cost-effective by diverting unresectable patients from operative to endoscopic palliation. Given the paucity of missed metastases on MRI, the yield of SL is marginal and its cost-effectiveness is poor. Future studies should address the utility of SL by both examining this issue prospectively and investigating the cost-effectiveness of endoscopic vs. surgical palliation in a manner that takes account of survival and quality of life data.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Endocrinology, Diabetes and Metabolism
Authors
Elliot Tapper, Bobby Kalb, Diego R. Martin, David Kooby, N. Volkan Adsay, Juan M. Sarmiento,